Skip to search formSkip to main contentSkip to account menu

NC100150

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

ferumoxtran-10

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor.
2004
2004
Long‐term imaging effects in rat liver after a single injection of an iron oxide nanoparticle based MR contrast agent
To investigate the duration of liver R2* enhancement and pharmacokinetics following administration of an iron oxide nanoparticle… 
2004
2004
Quantitative assessment of uptake and distribution of iron oxide particles (NC100150) in human melanoma xenografts by contrast‐enhanced MRI
The intratumor heterogeneity in uptake of iron oxide particles (NC100150) in human melanoma xenografts was studied by MRI and the… 
2004
2004
In and Ex Vivo MR Evaluation of Acute Myocardial Ischemia in Pigs by Determining R1 in Steady State After the Administration of the Intravascular Contrast Agent NC100150 Injection
Rationale and Objectives:To study the dose response in perfused and nonperfused myocardium by measuring relaxation rate (R1) in a… 
2003
2003
Multicenter phase-II trial of safety and efficacy of NC100150 for steady-state contrast-enhanced peripheral magnetic resonance angiography
Abstract.The aim of this study was to test the safety and efficacy of NC100150 injection for steady-state contrast-enhanced… 
2002
2002
Evaluation of a new ultrasmall superparamagnetic iron oxide contrast agent Clariscan®, (NC100150) for MRI of renal perfusion: Experimental study in an animal model
To determine the diagnostic value of a new ultrasmall superparamagnetic iron oxide Clariscan®, (NC100150) for the evaluation of… 
2000
2000
Effect of NC100150 injection on the 1H NMR linewidth of human whole blood ex vivo: Dependency on blood oxygen tension
The linewidth of the 1H NMR signal (7.05 T) of human whole blood titrated with a superparamagnetic contrast agent (NC100150… 
1999
1999
High-resolution magnetic resonance coronary angiography of the entire heart using a new blood-pool agent, NC100150 injection: comparison with invasive x-ray angiography in pigs.
Recent developments of novel magnetic resonance intravascular contrast agents with low T1 in blood and a long intravascular half… 
1999
1999
‘NC100150’, a preparation of iron oxide nanoparticles ideal for positive-contrast MR angiography
A laboratory-scale synthesis of NC100150 (iron oxide particles with an oxidized starch coating) was characterized by… 
1999
1999
First‐pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection
In this phase I clinical study, the new ultrasmall superparamagnetic iron oxide contrast agent, NC100150 Injection (Nycomed AS… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)